50242-599 : Xofluza 30 mg Oral Granule, for Suspension


NDC: 50242-599
Labeler: Genentech, Inc.
Product Type: Human Prescription Drug
Drug Name:  Xofluza
Dosage Form: Oral Granule, for Suspension
Application #: NDA214410
Rev. Date: 


NDC Package Codes:

  • 50242-599-01: 1 PACKET IN 1 CARTON (50242‑599‑01) / 1 GRANULE, FOR SUSPENSION IN 1 PACKET

Active Ingredients:

  • Baloxavir Marboxil

Dosage Strength:

  • 30 mg

Pharmaceutical Classes:

  • Chelating Activity [MoA]
  • Polymerase Acidic Endonuclease Inhibitor [EPC]
  • Polymerase Acidic Endonuclease Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 50242-583 Xofluza 40 mg/ml Oral Granule, for Solution by Genentech, Inc.
  • 50242-617 Xofluza 40 mg Oral Granule, for Suspension by Genentech, Inc.
  • 50242-877 Xofluza 80 mg Oral Tablet, Film Coated by Genentech, Inc.
  • 50242-828 Xofluza 20 mg Oral Tablet, Film Coated by Genentech, Inc
  • 50242-860 Xofluza 40 mg Oral Tablet, Film Coated by Genentech, Inc
  • 50090-4102 Xofluza 20 mg Oral Tablet, Film Coated by A-s Medication Solutions
  • 50090-4104 Xofluza 40 mg Oral Tablet, Film Coated by A-s Medication Solutions

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50242-599 QR Code

< Prev: 50242-583Next: 50242-617 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.